Myocardial infarction associated with erenumab: A case report

BACKGROUND: Monoclonal antibodies acting on the calcitonin gene‐related peptide or its receptor (CGRP‐mabs) are novel drugs for resistant migraine prophylaxis. As CGRP‐mabs cause inhibition of vasodilatation, their use is reserved to patients with no recent history of cardiovascular diseases. We rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Perino, Justine, Corand, Virginie, Laurent, Elise, Théophile, Hélène, Miremont‐Salamé, Ghada, Pariente, Antoine, Colas, Jean‐Laurent, Couffinhal, Thierry, Salvo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541222/
https://www.ncbi.nlm.nih.gov/pubmed/35620946
http://dx.doi.org/10.1002/phar.2706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541222/
https://www.ncbi.nlm.nih.gov/pubmed/35620946
http://dx.doi.org/10.1002/phar.2706

Ejemplares similares